Novum Digital Asset Alpha - Daily Analysis 13 August 2020
Turns out Thursday is terrific as I hope it is turning out for you as well!
In brief (TL:DR)
In today's issue...
Risk is in the air!
A slide in coronavirus infections in the U.S. is fueling risk appetite as investors bet that the worst may be over in the United States at a time when federal aid for the economy is still very much in full swing.
There is growing optimism that the coronavirus situation will get better, with a cavalcade of stimulus still coursing through the financial system.
And like the coronavirus, that optimism has been highly contagious as Asian stocks traded mostly up in the morning session with Tokyo's Nikkei 225 (+1.78%) and Seoul’s KOSPI (+0.21%) up, while Hong Kong’s Hang Seng Index (-0.23%) and Sydney’s ASX 200 (-0.67%), were down on fears that geopolitical tensions between the U.S. and China would affect these economies, which have greater exposure to China, more heavily.
Nevertheless, investors (rightly or wrongly) are betting that the rally in the stock market coinciding with a fall in U.S. government bond yields, may be signaling a normalization of the stock-bond relationship, and a sign of growing optimism over the economic future of America and the world.
To be sure, there are plenty of risks lingering, not least of which is the lack of meaningful profits from a large section of the industries on the S&P 500, a tech rally drive by few fundamental drivers, much like the dotcom boom, and unpredictable trading behavior underscored by skittish retail investors.
But as they say, make hay while the sun shines, and for now at least, the sun is shining on risk and risk takers.
1. A Coronavirus Vaccine Is Sexy, But Have You Seen Its Packaging?
As the world races to find a coronavirus vaccine, investors are eyeing stock of the most high profile companies such as Moderna (+0.80%) and Pfizer (+1.43%) and taking bets to win big.
But beneath the hype of developing a miracle cure, a far more pedestrian but no less important element of any coronavirus vaccine is its delivery mechanism.
Just like a Ferrari won't get you anywhere without a set of wheels, even the most effective coronavirus vaccine can be rendered useless without a safe delivery vehicle.
And when a vaccine is finally approved for manufacture, the rush to stock up on the ancillary products that are required to administer that vaccine, including needles, syringes, glass vials, rubber stoppers and adjuvants will provide a windfall for the companies making such equipment, and of course, their shareholders.
Take GlaxoSmithKline (+2.26%) for example, a pharmaceutical company that also manufactures the all important adjuvant for vaccines, including pandemic flu vaccines, which it is manufacturing to supply to multiple developers of coronavirus vaccines around the world.
An adjuvant is like the gun powder behind a bullet - if the coronavirus vaccine is the bullet, the adjuvant is the cartridge with the gunpowder that takes it there.
Then there's Becton Dickinson and Co. (+0.87%), which manufactures syringes and has factories spread across the U.S., Europe and Asia. Given that the company is able to manufacture needles in the billions, a surge in demand could be accommodated for, without any implosion of the firm's supply chain.
The last part of the equation is the glass vials which the vaccine will need to sit inside before being administered.
And while Corning (+1.33%) may be more closely associated with glass cookware and smartphone screens, it also manufactures the highly inert and chemically-stable glass vials that can be used to safely store a vaccine.
So while it may be sexy to gamble on who develops the coronavirus vaccine first, a good way to hedge is to take a punt on the companies which will provide the vehicles for which the vaccine will ultimately need to be delivered in.
2. China's Role As Factory To The World May Be Over
Designed elsewhere, made in China.
For the decades since the opening up of the Chinese economy, China has played the role of factory to the rest of the world.
But the Sino-U.S. trade war and China's rising belligerence over territorial claims in the South China Sea is pushing Apple and other tech giants to split their supply chains between the Chinese market and elsewhere, while also tacitly declaring that China's time as factory to the world is over.
Even before the coronavirus pandemic, manufacturers were moving their factories out of China, opening facilities in nearby Vietnam and Cambodia and other parts of Southeast Asia to avoid escalating tariffs on Chinese-made goods headed to U.S. markets.
The coronavirus pandemic, which saw highly optimized supply chains torn asunder however, made the shift to diversify production bases that much more urgent.
Already Foxconn (-0.93%), maker of the iPhone has stated that it can make Apple's most-prized product outside of China if needed, and there is growing expectation that a China-centric electronics supply chain will grow increasingly decentralized over the longer term.
But it's not just manufacturing in China that could become a problem.
By some estimates, a Trump administration ban on American companies doing business with Tencent's (+3.11%) WeChat, could see Apple forced to remove the ubiquitous and crucial app for millions of Chinese, from the Apple App Store, and that could see a decline in iPhone sales in China, by as much as 30%.
And that could put further pressure on Apple, for which China is a major market and an iPhone is seen as a status symbol, to shift production closer to its own home market, which will eat into margins.
For the longest time, the assumption was that China would make everything and anything that the rest of the world designed, but moving forward, "Made in China" may be replaced by something else.
3. Cryptocurrency Cleans Up Its Act
For all intents and purposes, 2020 has been a great year for Bitcoin and cryptocurrencies. As an asset class, Bitcoin has outperformed every other asset class bar none.
But when there's blood in the water the sharks will circle and it's estimated by digital asset intelligence firm CipherTrace, that the over the first five months of 2020, a whopping US$1.4 billion of ill-gotten funds were siphoned off via cryptocurrency crimes, making 2020 a potentially active year in regard to cryptocurrency-related thefts, hacks and fraud.
Based on current trends, 2020 looks set to come close to reaching the US$4.5 billion that was spirited away in 2019.
Part of the increase in the dollar-denominated quantums that were stolen this year has been of course due to the rise in the dollar value of cryptocurrencies, in particular Bitcoin.
But adjusted for changes in the dollar price for Bitcoin and other cryptocurrencies, 2020 will emerge as a relatively benign year for cryptocurrency crimes and related scams.
Part of the reason for that is because of increased awareness by existing holders of cryptocurrencies who are more sensitive to dubious offers and sending cryptocurrencies to unknown wallet addresses.
The other reason of course is heightened KYC (know your customer) and AML (anti-money laundering) policies at major cryptocurrency service providers and exchanges as the industry as a whole matures, and comes under greater regulatory scrutiny.
A recent interpretive letter by the U.S. Comptroller of the Currency clarifying the stance that legacy banks and financial institutions can now service cryptocurrency companies has also brought institutional tools and protections into the fray, offering a level of protection and security that had hitherto been wanting.
Even though the cryptocurrency industry is routinely maligned by the mainstream media as being the vehicle of choice to finance nefarious activities, less than 0.2% of funds accepted by cryptocurrency exchanges comes from criminal sources.
And given that cryptocurrency transactions can be traced openly on the blockchain, advanced tracing tools are making it harder for criminals to obfuscate the source of their ill-gotten cryptocurrency wealth, as demonstrated by the vigilantes actively monitoring digital wallet addresses owned by the US$3 billion PlusToken Ponzi scheme.
But it would be naive to think that the cryptocurrency industry will ever be completely free from scams and in that respect, the experience of the financial services sector should be telling.
With even big-name banks like HSBC (+2.80%) and Deutsche Bank (-0.35%) having either worked directly for, or provided banking services to, known criminals and drug dealers, the reality is that wherever there is money, crime will follow.
For its part though, cryptocurrency has certainly cleaned up its act from years prior.
Growing up is hard to do.
What can Digital Assets do for you?
While markets are expected to continue to be volatile, Novum Digital Asset Alpha's quantitative digital asset trading strategy has done consistently well and proved resilient.
Our flagship Novum Digital Asset Alpha returned over 20% to clients in May alone, with an annualized return target of 350% well on track.
Using our proprietary deep learning tools that actively filter out signal noise, our market agnostic approach provides one of the most sensible ways to participate in the nascent digital asset sector.
Aug 13, 2020
Important Risk Information
The information provided on this site is for informational purposes only. It is not to be construed as investment advice or a recommendation or offer to buy or sell any security. Prospective clients should always obtain and read an up-to-date product and/or services description or prospectus before deciding whether to invest. Any views expressed herein are those of Novum Alpha SPC (“the Company”) are based on available information, and are subject to change without notice. There are no guarantees regarding the achievement of investment objectives, target returns, or measurements such as alpha, tracking error, asset weightings and other information ratios. The views and strategies described may not be suitable for all clients. The Company does not provide tax or legal advice. Prospective subscribers should consult with a tax or legal advisor before making any investment decision. Investing in any investment product entails risks and there can be no assurance that the Company avoid incurring losses or achieve any of a prospective subscriber’s investment goals.
Performance quoted represents past performance, which is no guarantee of future results. Investment and principal value will fluctuate, so you may have a gain or loss when assets are sold. Current performance may be higher or lower than that quoted product’s expenses and other liabilities, and such product may be unable to meet its investment objective